Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Shakir, K. M. M.
space
  arrow  Potter, B. B.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

BRIEF REPORT

The Use of Bile Acid Sequestrants to Lower Serum Thyroid Hormones in Iatrogenic Hyperthyroidism

right arrow K. M. Mohamed Shakir; Rodney D. Michaels; James H. Hays; and Bonnie B. Potter

15 January 1993 | Volume 118 Issue 2 | Pages 112-113

Hyperthyroidism occasionally must be rapidly restored to euthyroidism, especially if it is associated with an emergent condition such as myocardial infarction. Several modalities are available to render endogenous hyperthyroid patients to a euthyroid state rapidly. Few therapeutic options, however, are available to rapidly treat hyperthyroidism caused by ingestion of excess thyroid hormones, except perhaps the use of ß-blockers. We observed hypothyroidism develop in two patients taking stable doses of levothyroxine after cholestyramine was added to their drug regimen. This finding led us to treat two patients with iatrogenic hyperthyroidism with cholestyramine. A euthyroid state was achieved in 72 to 96 hours whereas in three similar patients without cholestyramine treatment it had taken almost 8 days for serum thyroid hormone levels to fall into normal range. Our preliminary results suggest that bile acid sequestrants may be useful in treating exogenous thyroid-hormone-induced hyperthyroidism in emergent situations.

Author and Article Information
space

From the National Naval Medical Center and the Uniformed Services University of the Health Sciences, Bethesda, Maryland.
Requests for Reprints: CAPT K. M. M. Shakir, MC, USN, Division of Endocrinology and Metabolism, National Naval Medical Center, Bethesda, MD 20889-5000.
Acknowledgment: The authors thank Ms. Pat Rattal for editorial assistance.




This article has been cited by other articles:


Home page
J. Am. Coll. Nutr.Home page
A. D. Azezli, T. Bayraktaroglu, and Y. Orhan
The Use of Konjac Glucomannan to Lower Serum Thyroid Hormones in Hyperthyroidism
J. Am. Coll. Nutr., December 1, 2007; 26(6): 663 - 668.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. I. Surks and R. Sievert
Drugs and Thyroid Function
N. Engl. J. Med., December 21, 1995; 333(25): 1688 - 1694.
[Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1993 by the American College of Physicians.